This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • ECLIPSE Trial
      • Oral EPI-7386
      • SPLASH Trial
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASCO 2023
      • AUA 2023
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer

Conferences

Recent Abstracts
EAU 2023: In Young Patients, Is Prostate-Sparing Radical Cystectomy a Safe Option for Muscle Invasive Bladder Cancer? What About Reproductive Organ-Sparing in Women? Debate March 13, 2023
EAU 2023: Clinical Staging for Bladder Cancer: Have Imaging Techniques Reached a Point Where We Can Avoid TURBT – at Initial Diagnosis? After Neoadjuvant Therapy? March 13, 2023
EAU 2023: Case-Based Debate: What Is the Optimal Treatment for Patients with High-Risk Muscle-Invasive Bladder Cancer Scheduled for Radical Cystectomy? Case Presentation – Use of Both Neoadjuvant and Adjuvant Systemic Therapy? One Is Enough March 13, 2023
EAU 2023: European Urology Oncology Lecture: The Future of Systemic Treatment in Patients with Locally Advanced and Metastatic Renal Cell Carcinoma March 13, 2023
EAU 2023: State-of-the-Art Lecture: PARP Inhibitors: For Which Mutations and When? March 13, 2023
EAU 2023: State-of-the-Art Lecture: Optimal Treatment Sequencing in the Area of Triplet Therapies for Hormone-Sensitive Disease March 13, 2023
EAU 2023: Debate: Is There Any Added Value of Docetaxel in Combination with ADT and ARPI for the Treatment of mHSPC? March 13, 2023
EAU 2023: State-of-the-Art Lecture: What Are the Best Predictive Factors for Successful Treatment with Lu PSMA? March 13, 2023
EAU 2023: State-of-the-Art Lecture: When and How to Sequence (Molecular Testing)? March 13, 2023
EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Surgical Approach +/- Radiotherapy +/- Systemic Treatment March 13, 2023
EAU 2023: Debate: Low-Volume Disease at Conventional Imaging, 5 Bone Metastases at PSMA PET/CT March 13, 2023
EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Radiotherapeutic Approach +/- Systemic Treatment March 13, 2023
EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Subtypes of Prostate Cancer and How They Change our Management March 13, 2023
EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Systemic Therapy: What and for how long? March 13, 2023
EAU 2023: State-of-the-Art Lecture: Patient-Related Factors That Guide Treatment Decisions March 13, 2023
Delaying Treatment for Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows March 12, 2023
Difference Between “Growers” and “Showers” Revealed March 12, 2023
EAU 2023: State-of-the-Art Lecture When and How to Stage? March 12, 2023
EAU 2023: Debate: High-Risk BRCA Mutated Case with N0 M0 at Conventional Imaging and Multiple cN1 at PSMA: What to Do? March 12, 2023
EAU 2023: LuTectomy: A Prospective Study of Dosimetry, Safety and Potential Benefit of Upfront 177Lu-PSMA-617 Radioligand Therapy Prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer March 12, 2023
Page 13 of 518
  • Start
  • Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free